Frontiers in Chemistry,
Journal Year:
2022,
Volume and Issue:
10
Published: Dec. 6, 2022
The
economical
and
societal
impact
of
COVID-19
has
made
the
development
vaccines
drugs
to
combat
SARS-CoV-2
infection
a
priority.
While
spike
protein
been
widely
explored
as
drug
target,
helicase
(nsp13)
does
not
have
any
approved
medication.
shares
99.8%
similarity
with
its
SARS-CoV-1
homolog
was
shown
be
essential
for
viral
replication.
This
review
summarizes
builds
on
existing
research
inhibitors
helicases.
Our
analysis
toxicity
specificity
these
compounds,
set
road
going
forward
repurposing
new
inhibitors.
Viruses,
Journal Year:
2023,
Volume and Issue:
15(7), P. 1515 - 1515
Published: July 7, 2023
Background:
Nirmatrelvir/ritonavir
(NMV/r)
and
three-day
course
remdesivir
(3RDV)
have
been
approved
as
early
treatments
for
COVID-19
outpatients
not
requiring
supplemental
oxygen.
Real-life
data
on
the
efficacy
of
antivirals
among
immunocompromised
patients
or
directly
comparing
their
effectiveness
in
preventing
hospitalization
and/or
death
are
scarce.
Methods:
Prospective,
observational
study
conducted
a
tertiary
care
hospital,
from
1
January
2022
until
15
March
2023,
during
prevalence
Omicron
variant.
Inverse
probability
treatment
weighting
(IPTW)
was
used
to
account
differences
between
groups.
Results:
We
included
521,
mainly
(56%),
our
analysis;
356
(68.3%)
received
3RDV
165
(31.7%)
NMV/r.
Overall,
15/521
(2.9%)
met
primary
end-point
at
30
days
(3RDV
arm:
10/356,
2.8%
vs.
NMV/r
5/165,
3%,
p
=
1).
On
IPTW-adjusted
univariable
analysis,
choice
did
affect
outcomes.
In
multivariable
logistic
regression
we
found
that
one
(OR
0.26,
95%CI
0.07–0.99,
0.049)
two
0.06,
0.01–0.55,
0.014)
vaccine
booster
shots
reduced
risk
adverse
Conclusion:
patient
population
high-risk,
immunocompromised,
vaccinated
variant,
were
equally
effective
prevention
death.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(5), P. 1144 - 1144
Published: March 4, 2024
The
SARS-CoV-2
virus
and
its
mutations
have
affected
human
health
globally
created
significant
danger
for
the
of
people
all
around
world.
To
cure
this
virus,
Angiotensin
Converting
Enzyme-2
(ACE2)
receptor,
main
protease
(Mpro),
spike
proteins
were
found
to
be
likely
candidates
synthesis
novel
therapeutic
drug.
In
past,
capable
engaging
in
interaction
with
a
wide
variety
ligands,
including
both
manmade
plant-derived
small
molecules.
Pyrus
communis
L.,
Ginko
bibola,
Carica
papaya,
Syrian
rue,
Pimenta
dioica
some
plant
species
that
studied
their
tendency
interact
(Mpro)
research
project
(6LU7).
This
scenario
investigates
geometry,
electronic,
thermodynamic
properties
computationally.
Assessing
intermolecular
forces
phytochemicals
targets
Mpro
protein
(SP)
resulted
recognition
compound,
kaempferol,
as
most
potent
binding
ligand,
−7.7
kcal
mol−1.
Kaempferol
interacted
ASP-187,
CYS-145,
SER-144,
LEU
141,
MET-165,
GLU-166
residues.
Through
additional
molecular
dynamic
simulations,
stability
ligand–protein
interactions
was
assessed
100
ns.
remained
intact
33%
contact
strength
phenolic
OH
group.
We
noted
change
torsional
conformation,
dynamics
simulation
showed
potential
variation
range
from
3.36
7.44
against
45–50-degree
angle
rotation.
SAR,
pharmacokinetics,
drug-likeness
characteristic
investigations
kaempferol
may
suitable
candidate
serve
model
designing
developing
new
anti-COVID-19
medicines.
Molecular and Cellular Probes,
Journal Year:
2024,
Volume and Issue:
77, P. 101973 - 101973
Published: July 24, 2024
The
coronavirus
disease
2019
(COVID-19)
caused
by
the
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
has
killed
millions
of
people
and
continues
to
wreak
havoc
across
globe.
This
sudden
deadly
pandemic
emphasizes
necessity
for
anti-viral
drug
development
that
can
be
rapidly
administered
reduce
morbidity,
mortality,
virus
propagation.
Thus,
lacking
efficient
anti-COVID-19
treatment,
especially
given
lengthy
process
as
well
critical
death
tool
been
associated
with
SARS-CoV-2
since
its
outbreak,
repurposing
(or
repositioning)
constitutes
so
far,
ideal
ready-to-go
best
approach
in
mitigating
viral
spread,
containing
infection,
reducing
COVID-19-associated
rate.
Indeed,
based
on
molecular
similarity
previous
coronaviruses
(CoVs),
repurposed
drugs
have
reported
hamper
replication.
Therefore,
understanding
inhibition
mechanisms
replication
chemicals
known
block
CoV
multiplication
is
crucial,
it
opens
way
particular
treatment
options
COVID-19
therapeutics.
In
this
review,
we
highlighted
basics
underlying
drug-repurposing
strategies
against
SARS-CoV-2.
Notably,
discussed
replication,
involving
including
proteases
(3C-like
protease,
3CL
Animal Models and Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 7, 2025
Acquired
immune
deficiency
syndrome
(AIDS)
is
the
name
used
to
describe
several
potentially
life-threatening
infections
and
disorders
that
happen
when
HIV
has
severely
compromised
system.
The
primary
effect
of
decrease
host
immunity,
exposing
external
pathogens.
development
pharmaceutical
drugs
directly
cure
infection
crucial
because
current
wide-ranging
epidemic
HIV.
Most
therapeutic
anti-HIV
are
nucleosides.
However,
their
high
toxicity
potential
for
drug
resistance
restrict
use.
Many
most
effective
clinical
inhibit
HIV,
activation
latent
AIDS
have
been
obtained
from
natural
sources.
This
review
focuses
on
medicinal
products
treating
managing
AIDS.
Notwithstanding,
further
research
studies
needed
understand
subject
its
dynamics.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: March 3, 2025
Abstract
Natural
Products
(NPs)
are
increasingly
utilized
worldwide
for
their
potential
therapeutic
benefits,
including
central
nervous
system
(CNS)
disorders.
Studies
have
shown
açai
berries
mitigating
Parkinson’s
disease
progression
through
dopaminergic
neuroprotection
via
Nrf-2
HO-1
pathways.
Ashwagandha,
an
evergreen
shrub,
has
as
a
neurodegenerative
disorders
axonal
regeneration
in
Aβ25-35-treated
cortical
neurons
vitro.
In
most
cases,
promising
NPs
tested
using
vitro
assays
or
simpler
systems
during
the
early
stages
of
drug
discovery.
However,
critical
challenge
lies
lack
data
on
blood-brain
barrier
(BBB)
penetration,
which
is
significant
determinant
successful
development
CNS
drugs.
Our
first
goal
was
to
test
our
in-house
NP
constituent
library
Parallel
Artificial
Membrane
Permeability
Assay
(PAMPA-BBB),
with
aim
understanding
BBB-penetration
potential.
Of
constituents
tested,
255
were
found
moderate
high
BBB
permeability.
next
understand
if
these
compounds
could
exhibit
toxicity.
Neuronal
viability
and
neurite
outgrowth
performed
this
subset
identify
neurotoxicity
Around
35%
showed
inhibition.
The
habitual
widespread
consumption
underscores
importance
subjecting
additional
testing
validation
vivo
ascertain
detrimental
effects.
Understanding
permeability
assessing
mechanisms
will
significantly
benefit
discovery
community.
Chemistry & Biodiversity,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 12, 2025
The
investigation
of
natural
products
is
a
valid
strategy
to
identify
compounds
active
against
coronaviruses.
We
herein
report
the
screening
Baccharis
and
Campovassouria
plant
species
murine
betacoronavirus
hepatitis
virus-3
(MHV-3),
assays
that
can
be
carried
out
in
BSL-2
facilities.
These
genera
occur
exclusively
Americas
are
source
secondary
metabolites
with
antiviral
anti-inflammatory
activity.
cruciata
emerged
as
most
from
screening,
its
phytochemical
afforded
discovery
new
isomer
leptocarpin,
3-epi-leptocapin
(1),
addition
sesquiterpenes
lactones
leptocarpin
(2)
arturin
(3),
along
umbelliferone
(4).
structures
were
elucidated
by
extensive
mono-
two-dimensional
1H
13C
NMR
data
analysis.
activity
isolated
was
also
assayed
Calu-3
cells
infected
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
All
inhibited
SARS-CoV-2
replication,
reduction
viral
load
approximately
1.7-2.0
log
when
tested
at
7.5
µM.
To
evaluate
potential
activity,
A549
stimulated
IFN-γ
TNF-α.
Both
3-epi-leptocarpin
(1)
(4)
interleukin-6
(IL-6)
IL-8
release
significantly.
Compound
1
reduced
production
reactive
oxygen
(ROS)
cells,
assessed
flow
cytometry
using
DCFH-DA,
whereas
4
exhibited
ROS
values
seven-fold
higher
than
basal
level.
Our
results
highlight
C.
promising
bioactive
compounds,
which
deserve
future
investigations
explore
their
for
development
therapeutic
agents
inflammatory
diseases.
Global Health,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
Background:
SARS‐CoV‐2
is
a
positive‐sense
single‐stranded
RNA
virus
that
has
propensity
for
infecting
epithelial
cells
and
the
respiratory
system.
The
two
important
proteins,
structural
nonstructural
make
architecture
of
this
virus.
Aim:
This
research
aimed
at
studying
significant
mutations
in
spike
protein
variants
concern
(VoCs)
finding
shared
among
omicron
other
four
(alpha,
beta,
gamma,
delta).
purpose
study
was
to
draw
comparisons
between
wild
type
mutant
followed
by
identifying
potent
inhibitors
(ligand)
could
be
used
against
its
latest
VoC.
Methodology:
In
research,
we
had
studied
16
major
as
well
(6)
present
region
SARS‐CoV‐2.
Subsequently,
determined
structure
wild‐type
from
Protein
Data
Bank
(PDB)
with
ID
7R4I.
Furthermore,
variant
modeled
SWISS‐MODEL.
ligand
dataset
also
collected
literature
different
databases.
Both
proteins
were
docked
database
Molecular
Operating
Environment
(MOE).
docking
analysis
performed,
best
molecules,
AZ_2
AZ_13,
finalized
based
on
their
energy
values,
interactions,
scores
our
proteins.
Results:
demonstrated
score
−6.1753
MOE,
values
−4.3889
−6.1753.
It
formed
key
hydrogen
bond
interactions.
AZ_13
showed
−5.9,
−9.3
forming
donor
acceptor
interactions
Asp950
(3.06
Å),
Ile312
(3.13
Glu309
(3.27
Å).
These
suggest
strong
binding
affinity
potential
efficacy.
Thus,
work
emphasized
identification
target‐based
drug
variant.
Outcomes:
Based
computational
it
suggested
proposed
compound
can
remedy
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: Feb. 16, 2023
The
Coronavirus
Diseases
2019
(COVID-19)
has
been
rapidly
spreading
globally
and
caused
severe
harm
to
the
health
of
people
a
substantial
social
burden.
In
response
this
situation,
experts
around
world
have
considered
various
treatments,
including
use
traditional
medicine.
Traditional
Tibetan
medicine
(TTM),
one
medicines
in
China,
played
an
important
role
treatment
infectious
diseases
history.
It
formed
solid
theoretical
foundation
accumulated
rich
experience
diseases.
review,
we
provide
comprehensive
introduction
basic
theory,
strategies,
commonly
used
drugs
TTM
for
COVID-19.
addition,
efficacies
potential
mechanisms
these
against
COVID-19
are
discussed
based
on
available
experimental
data.
This
review
may
information
research,
clinical
application
drug
development
or
other
More
pharmacological
studies
needed
reveal
therapeutic
active
ingredients
Antiviral Research,
Journal Year:
2023,
Volume and Issue:
219, P. 105731 - 105731
Published: Oct. 12, 2023
Despite
the
advances
in
contemporary
medicine
and
availability
of
numerous
innovative
therapies,
effective
treatment
prevention
SARS-CoV-2
infections
pose
a
challenge.
In
search
for
new
anti-SARS-CoV-2
drug
candidates,
natural
products
are
frequently
explored.
Here,
fifteen
cyanopeptolins
(CPs)
were
isolated
from
Baltic
cyanobacterium
Nostoc
edaphicum
tested
against
SARS-CoV-2.
Of
these
depsipeptides,
Arg-containing
structural
variants
showed
strongest
inhibition
Delta
infection
A549ACE2/TMPRSS2
cells.
The
functional
assays
indicated
direct
interaction
CP978
with
virions.
also
induced
significant
decline
virus
replication
primary
human
airway
epithelial
cells
(HAE).
four
variants,
Wuhan,
Alpha,
Omicron
Delta,
only
Wuhan
was
not
affected
by
CP978.
Finally,
analyses
application
confocal
microscopy
pseudoviruses
that
CP978-mediated
viral
results
binding
cyanopeptolin
coronaviral
S
protein.
Considering
potency
mode
action
CP978,
significance
peptide
as
antiviral
candidate
should
be
further